ShangPharma Financial Statements From 2010 to 2024

ShangPharma Corp financial statements provide useful quarterly and yearly information to potential ShangPharma Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on ShangPharma Corp financial statements helps investors assess ShangPharma Corp's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting ShangPharma Corp's valuation are summarized below:
ShangPharma Corp does not presently have any fundamental trend indicators for analysis.
Check ShangPharma Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ShangPharma Corp's main balance sheet or income statement drivers, such as , as well as many indicators such as . ShangPharma financial statements analysis is a perfect complement when working with ShangPharma Corp Valuation or Volatility modules.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

ShangPharma Corp Company Return On Asset Analysis

ShangPharma Corp's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current ShangPharma Corp Return On Asset

    
  0.02  
Most of ShangPharma Corp's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ShangPharma Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition
Based on the latest financial disclosure, ShangPharma Corp has a Return On Asset of 0.02. This is much higher than that of the sector and significantly higher than that of the Pharmaceutical Products industry. The return on asset for all United States stocks is notably lower than that of the firm.

ShangPharma Corp Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ShangPharma Corp's current stock value. Our valuation model uses many indicators to compare ShangPharma Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ShangPharma Corp competition to find correlations between indicators driving ShangPharma Corp's intrinsic value. More Info.
ShangPharma Corp is currently regarded as top stock in return on asset category among its peers. It also is currently regarded as top stock in profit margin category among its peers fabricating about  2.50  of Profit Margin per Return On Asset. Comparative valuation analysis is a catch-all technique that is used if you cannot value ShangPharma Corp by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Pair Trading with ShangPharma Corp

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ShangPharma Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ShangPharma Corp will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Consideration for investing in ShangPharma Stock

If you are still planning to invest in ShangPharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ShangPharma Corp's history and understand the potential risks before investing.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
CEOs Directory
Screen CEOs from public companies around the world
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance